Discounted Cash Flow
Alignment Healthcare, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2019 | $757.0m | $-44.7m | $9.2m | -5.9% | $-0.33 |
| 2020 | $959.2m (26.7%) | $-22.9m (48.7%) | $7.5m (-19.0%) | -2.4% (59.6%) | $-0.15 (54.5%) |
| 2021 | $1.2b (21.7%) | $-195.3m (-751.8%) | $-78.8m (-1155.8%) | -16.7% (-599.7%) | $-1.14 (-660.0%) |
| 2022 | $1.4b (22.8%) | $-149.5m (23.4%) | $-69.2m (12.2%) | -10.4% (37.6%) | $-0.83 (27.2%) |
| 2023 | $1.8b (27.2%) | $-148.0m (1.0%) | $-95.2m (-37.5%) | -8.1% (22.2%) | $-0.79 (4.8%) |
| 2024 | $2.7b (48.3%) | $-128.0m (13.5%) | $-6.6m (93.0%) | -4.7% (41.7%) | $-0.67 (15.2%) |
| 2025 | $3.9b (46.1%) | $-724.0k (99.4%) | $113.1m (1802.0%) | -0.0% (99.6%) | $0.00 (100.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.